Item 2.02 Results of Operations and Financial Condition.

On January 18, 2023, iRadimed Corporation issued a press release (the "Press Release") announcing its preliminary financial results for the fourth quarter ended December 31, 2022, and 2023 guidance. A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that Section. Furthermore, such information, including Exhibit 99.1, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits



Exhibit No. Description
99.1          Press release dated January 18, 2023.
104         Cover Page Interactive Data File (formatted in Inline XBRL and
            contained in Exhibit 101)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses